CUBIST PHARMACEUTICALS INC's ticker is and the CUSIP is 229678AD9. A total of 40 filers reported holding CUBIST PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $1,916,000 | +60.3% | 553,000 | +7.8% | 0.00% | – |
Q3 2014 | $1,195,000 | -94.2% | 513,000 | -93.9% | 0.00% | -100.0% |
Q2 2014 | $20,485,000 | -35.3% | 8,357,000 | -32.5% | 0.00% | -40.0% |
Q1 2014 | $31,651,000 | +6.1% | 12,388,000 | +1.0% | 0.01% | 0.0% |
Q4 2013 | $29,842,000 | +1313.0% | 12,268,000 | +1206.5% | 0.01% | – |
Q3 2013 | $2,112,000 | -92.3% | 939,000 | -94.0% | 0.00% | -100.0% |
Q2 2013 | $27,279,000 | – | 15,571,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polar Asset Management Partners Inc. | 42,638,000 | $147,969,000 | 7.88% |
EQUITEC SPECIALISTS, LLC | 7,624,000 | $26,412,000 | 6.82% |
PIPER SANDLER & CO. | 3,852,000 | $13,345,000 | 6.50% |
WOLVERINE ASSET MANAGEMENT LLC | 54,453,000 | $188,885,000 | 3.68% |
WHITEBOX ADVISORS LLC | 13,700,000 | $47,462,000 | 1.90% |
CAMDEN ASSET MANAGEMENT L P /CA | 14,650,000 | $50,753,000 | 1.88% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 21,630,000 | $74,935,000 | 0.96% |
Jabre Capital Partners S.A. | 2,500,000 | $8,693,000 | 0.89% |
BNP PARIBAS FINANCIAL MARKETS | 11,000,000 | $38,108,179,000 | 0.14% |
BLACKROCK ADVISORS LLC | 22,363,000 | $77,474,000 | 0.08% |